Pharmaceutical composition comprising alpha-glucosidase inhibitor

Composition pharmaceutique contenant un inhibiteur de l'alpha-glucosidase

Abstract

La présente invention porte sur une composition pharmaceutique contenant du voglibose, de l'acarbose ou du miglitol, destinée à être utilisée pour la prévention et le traitement des cas de diabète de type 2 (non insulinodépendant) dans lesquels l'hyperglycémie ne peut être régulée par un régime alimentaire ou par l'exercice physique.
The present invention relates to a pharmaceutical composition comprising voglibose, acarbose or miglitol so as to be used in the prophylaxis and treatment of type 2 diabetes (non-insulin dependent) mellitus cases wherein hyperglycemia cannot be controlled by diet or exercise.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (6)

    Publication numberPublication dateAssigneeTitle
    CN-101590007-ADecember 02, 2009北京瑞伊人科技发展有限公司;安 英Metformin hydrochloride/voglibose sugar-lowering oral preparation composition and preparation method thereof
    JP-2001002567-AJanuary 09, 2001Takeda Chem Ind Ltd, 武田薬品工業株式会社Sustained release preparation containing water-soluble medicine
    US-2002177602-A1November 28, 2002Beth Anne PiperAntidiabetic formulation and method
    WO-2008038304-A2April 03, 2008Jegannathan SrinivasTherapeutical formulation comprising an alpha-glucosidase inhibitor and a nitric oxide scavenger.
    WO-2009135951-A2November 12, 2009Atacama Labs OyProcess for preparing a tablet comprising metformin
    WO-2012093972-A1July 12, 2012Mahmut BilgicWater soluble dosage forms

NO-Patent Citations (2)

    Title
    DATABASE WPI Week 201009, Derwent Publications Ltd., London, GB; AN 2009-S24059
    None

Cited By (0)

    Publication numberPublication dateAssigneeTitle